Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ETONETON
Showing 8 of 25 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ETON PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 652,303 shares of ETON (ETON PHARMACEUTICALS INC), worth $23.6M as of 2026-Q2. The position was increased (+12.9% shares). ETON represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$23.6M

Current Shares

652,303

Total Value Change

+$22M

Total Shares Change

+379,607

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
652,303
+12.9%
$23.6M0.0%$36.20
32
2026-Q1
Increased
577,666
+2.2%
$14.3M0.0%$17.45
29
2025-Q4
Decreased
565,051
-1.6%
$9.6M0.0%$16.79
0
2025-Q3
Decreased
574,030
-3.2%
$12.5M0.0%$22.48
0
2025-Q2
Increased
592,865
+98.8%
$8.5M0.0%$14.01
44
2025-Q1
Increased
298,248
+11.0%
$3.9M0.0%$13.02
30
2024-Q4
Decreased
268,646
-1.5%
$3.6M0.0%$13.03
0
2024-Q3
Increased
272,696
+13.5%
$1.6M0.0%$5.80
29

Other major holders of ETON: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used